Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 17 studies | 27% ± 10% | |
| oligodendrocyte | 13 studies | 30% ± 11% | |
| macrophage | 11 studies | 27% ± 9% | |
| oligodendrocyte precursor cell | 11 studies | 27% ± 13% | |
| fibroblast | 10 studies | 21% ± 5% | |
| astrocyte | 10 studies | 32% ± 14% | |
| GABAergic neuron | 8 studies | 38% ± 20% | |
| glutamatergic neuron | 8 studies | 42% ± 25% | |
| interneuron | 7 studies | 35% ± 21% | |
| microglial cell | 7 studies | 26% ± 6% | |
| epithelial cell | 7 studies | 34% ± 18% | |
| basal cell | 6 studies | 29% ± 17% | |
| ciliated cell | 6 studies | 25% ± 8% | |
| neuron | 5 studies | 32% ± 12% | |
| myeloid cell | 5 studies | 22% ± 4% | |
| adipocyte | 5 studies | 23% ± 5% | |
| endothelial cell of lymphatic vessel | 5 studies | 23% ± 5% | |
| dendritic cell | 4 studies | 21% ± 3% | |
| classical monocyte | 3 studies | 21% ± 4% | |
| non-classical monocyte | 3 studies | 20% ± 4% | |
| granule cell | 3 studies | 19% ± 1% | |
| retinal ganglion cell | 3 studies | 39% ± 3% | |
| amacrine cell | 3 studies | 24% ± 8% | |
| retinal pigment epithelial cell | 3 studies | 24% ± 7% | |
| lymphocyte | 3 studies | 21% ± 5% | |
| rod bipolar cell | 3 studies | 21% ± 7% | |
| type I pneumocyte | 3 studies | 20% ± 2% | |
| abnormal cell | 3 studies | 20% ± 5% | |
| T cell | 3 studies | 18% ± 2% | |
| alveolar macrophage | 3 studies | 25% ± 8% | |
| monocyte | 3 studies | 26% ± 1% | |
| goblet cell | 3 studies | 33% ± 23% | |
| smooth muscle cell | 3 studies | 18% ± 1% | |
| mast cell | 3 studies | 20% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 100% | 2858.90 | 21 / 21 | 100% | 21.05 | 504 / 504 |
| esophagus | 100% | 3207.93 | 1445 / 1445 | 100% | 23.10 | 183 / 183 |
| lung | 100% | 2890.13 | 578 / 578 | 100% | 20.64 | 1155 / 1155 |
| ovary | 100% | 2618.55 | 180 / 180 | 100% | 14.97 | 430 / 430 |
| brain | 100% | 2675.76 | 2640 / 2642 | 100% | 30.94 | 705 / 705 |
| breast | 100% | 3262.07 | 459 / 459 | 100% | 22.29 | 1117 / 1118 |
| uterus | 100% | 3035.72 | 170 / 170 | 100% | 19.97 | 458 / 459 |
| thymus | 100% | 3018.74 | 653 / 653 | 100% | 18.71 | 603 / 605 |
| stomach | 100% | 2029.22 | 359 / 359 | 100% | 19.76 | 285 / 286 |
| prostate | 100% | 2752.81 | 245 / 245 | 100% | 15.87 | 500 / 502 |
| intestine | 100% | 2804.50 | 966 / 966 | 99% | 20.29 | 524 / 527 |
| kidney | 100% | 2247.19 | 89 / 89 | 99% | 17.98 | 894 / 901 |
| adrenal gland | 100% | 2731.84 | 258 / 258 | 98% | 17.89 | 226 / 230 |
| pancreas | 99% | 1348.59 | 324 / 328 | 99% | 20.90 | 176 / 178 |
| skin | 100% | 3513.23 | 1809 / 1809 | 96% | 18.63 | 451 / 472 |
| liver | 99% | 927.73 | 223 / 226 | 68% | 5.63 | 275 / 406 |
| adipose | 100% | 3355.18 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 15.53 | 29 / 29 |
| spleen | 100% | 3667.21 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 21.67 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 9.79 | 1 / 1 |
| blood vessel | 100% | 2645.51 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 1730.50 | 850 / 861 | 0% | 0 | 0 / 0 |
| muscle | 99% | 1377.44 | 791 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 82% | 1595.04 | 760 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 79% | 9.73 | 63 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0090522 | Biological process | vesicle tethering involved in exocytosis |
| GO_0051607 | Biological process | defense response to virus |
| GO_0015031 | Biological process | protein transport |
| GO_0006904 | Biological process | vesicle docking involved in exocytosis |
| GO_0016241 | Biological process | regulation of macroautophagy |
| GO_0006887 | Biological process | exocytosis |
| GO_0000281 | Biological process | mitotic cytokinesis |
| GO_0006893 | Biological process | Golgi to plasma membrane transport |
| GO_0090148 | Biological process | membrane fission |
| GO_0090543 | Cellular component | Flemming body |
| GO_0005829 | Cellular component | cytosol |
| GO_0016020 | Cellular component | membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0000145 | Cellular component | exocyst |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | EXOC1 |
| Protein name | EXOC1 protein Exocyst complex component 1 (Exocyst complex component Sec3) |
| Synonyms | SEC3L1 SEC3 BM-012 |
| Description | FUNCTION: Component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane.; FUNCTION: (Microbial infection) Has an antiviral effect against flaviviruses by affecting viral RNA transcription and translation through the sequestration of elongation factor 1-alpha (EEF1A1). This results in decreased viral RNA synthesis and decreased viral protein translation. . |
| Accessions | ENST00000381295.7 [Q9NV70-1] ENST00000346134.11 [Q9NV70-1] ENST00000349598.6 [Q9NV70-2] Q9NV70 A0PJ99 |